Preformulation Study for Seven Solid Forms of Dotinurad
Jiyong Liu,Dier Shi,Shuna Liu,Kaxi Yu,Xiurong Hu
DOI: https://doi.org/10.1021/acs.cgd.3c00587
IF: 4.01
2023-01-01
Crystal Growth & Design
Abstract:Dotinurad, a novel selective urate reabsorption inhibitor,wasstudied for preformulation beneficiation by supramolecular methods.Two polymorphic forms (form I, form II), a monohydrate, and four solvateswere prepared and characterized by single-crystal X-ray diffraction,powder X-ray diffraction, and thermal analysis, which enabled therespective molecular conformation, intermolecular interactions, andpacking arrangements to be determined. Combined with Hirshfeld surfaceanalysis and energy networks, the stability and conformations of theabove seven solid forms were studied by thermal analysis, crystalstructure, and experimental results of solvent-mediated transitionsand heat-treated transitions. Interestingly, form I and five solvateswere transformed to form II under solvent suspension easily and quickly.The desolvation of DT solvates resulted in form II, which is mainlyrelated to the hydrogen bonds between DT molecules and solvents. Seven solid state forms of Dotinurad(DT), including twopolymorphs and five pseudopolymorphs, were prepared and characterizedby various methods. Their stability and mutual conversion were furtheranalyzed, combined with respective molecular conformation, inter-and intramolecular interactions, and packing arrangements. These pioneeringstudies are helpful in understanding the polymorphism and provideda theoretical basis for the production and clinical application ofDT.